EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents

Yili Dai iD, Linjun Sun, Yan Tan, Wenyu Xu, Shu Liu, Jing Zhou, Yalin Hu, Jieying Lin, Xu Yao, Pengbing Mi, Xing Zheng

Chemical Biology & Drug Design · 2023-12 · 102 (6) · 1643-1657

DOI: 10.1111/cbdd.14347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 13.09.2023. Verfasst von Yili Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Triterpenes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ursolic acid (UA) is a pentacyclic triterpenoid, which exhibits many biological activities, particularly in anti‐cardiovascular and anti‐diabetes. The further application of UA is greatly limited due to its low bioavailability and poor water solubility. Up to date, various UA derivatives have been designed to overcome these shortcomings. In this paper, the authors reviewed the development of UA derivatives as the anti‐diabetes anti‐cardiovascular reagents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesSolubilityUrsolic Acid

Stichwörter der Autor:innen

anti-cardiovascularanti-diabetesursolic acid derivatives

Substanzen

TriterpenesUrsolic Acid

Autor:innen und Institutionen

  • Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China.
  • Department of Pharmacy, Hunan Vocational College of Science and Technology, Changsha, China.

ORCID-Profile: Yili Dai

Zitieren

APA

Dai, Y., Sun, L., Tan, Y., Xu, W., Liu, S., Zhou, J., Hu, Y., Lin, J., Yao, X., Mi, P., & Zheng, X. (2023). Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design, 102(6), 1643-1657. https://doi.org/10.1111/cbdd.14347

Vancouver

Dai Y, Sun L, Tan Y, Xu W, Liu S, Zhou J, et al. Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design. 2023;102(6):1643-1657. doi:10.1111/cbdd.14347

BibTeX
@article{Dai2023,
  author = {Dai, Yili and Sun, Linjun and Tan, Yan and Xu, Wenyu and Liu, Shu and Zhou, Jing and Hu, Yalin and Lin, Jieying and Yao, Xu and Mi, Pengbing and Zheng, Xing},
  title = {Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {6},
  pages = {1643--1657},
  doi = {10.1111/cbdd.14347}
}
Kostenlos starten →